RxDoctor Payments Data

Jason Johnson, MD

Obstetrics & Gynecology · Salt Lake City, UTNPI 1376638718

Payments from drug & device makers

What this record shows

This record is dominated by education: $6,038 of the $9,060 with a category attached, or 66.6%. Intuitive Surgical accounts for 69.5% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $6,113, 3.5 times the $1,743 reported in 2019. Among obstetrics & gynecology clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,060in general payments, 2019–2025

Across 45 payments — averaging $201.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$6K
  • Duchesnay USA Incorporated$2K
  • AbbVie$306
  • Hologic Sales And Service, LLC$232
  • Conmed Corporation$108
  • Johnson & Johnson$76
  • plus $403 from 10 others

What the payments were for

  • Speaking & faculty fees$1,50017%
  • Food & beverage$1,52217%
  • Education$6,03867%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,060 in reported general payments places this provider in the 90th percentile of 294 obstetrics & gynecology providers in Utah.

See all obstetrics & gynecology providers in Utah

Medicare billing

Part B allowed, 2024
$12,726
Medicare patients
46
Services billed
65

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron18$12,696
Estradiol113$4,056
ProgesteroneProgesterone, Micronized33$799
Estradiol (Twice Weekly)Estradiol12$672
Zolpidem Tartrate23$324
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip12$163
Oxybutynin Chloride ErOxybutynin Chloride17$154
Levothyroxine Sodium16$123
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen13$105
Clonazepam21$30

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$74$12,69618 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 294 obstetrics & gynecology providers in Utah.

Other obstetrics & gynecology in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →